Firing Up Glycolysis: BCG Vaccination Effects on Type 1 Diabetes Mellitus

Rinke Stienstra, Mihai G. Netea*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

In addition to the impact of Bacillus Calmette–Guerin (BCG) vaccination on antimicrobial host defence, a novel study reveals beneficial effects on glycaemic control in patients with long-standing type 1 diabetes mellitus (T1DM). These effects are ascribed to an accelerated glucose consumption in immune cells due to increased glycolysis and reduced oxidative phosphorylation.

Original languageEnglish
Pages (from-to)813-814
JournalTrends in Endocrinology and Metabolism
Volume29
Issue number12
Early online date13 Oct 2018
DOIs
Publication statusPublished - Dec 2018

Fingerprint

Dive into the research topics of 'Firing Up Glycolysis: BCG Vaccination Effects on Type 1 Diabetes Mellitus'. Together they form a unique fingerprint.

Cite this